that the respondent
No.3 i.e. the National Pharmaceutical Pricing Authority (NPPA) is
wrongly interpreting DPCO 2013 to insist on price ceiling for
formulations ... also
challenged communication dated 20.06.2014 issued by respondent
No.3-NPPA to the Department of Pharmaceutical, which purports
to interpret DPCO 2013, contrary
that the respondent
No.3 i.e. the National Pharmaceutical Pricing Authority (NPPA) is
wrongly interpreting DPCO 2013 to insist on price ceiling for
formulations ... also
challenged communication dated 20.06.2014 issued by respondent
No.3-NPPA to the Department of Pharmaceutical, which purports
to interpret DPCO 2013, contrary
that the respondent
No.3 i.e. the National Pharmaceutical Pricing Authority (NPPA) is
wrongly interpreting DPCO 2013 to insist on price ceiling for
formulations ... also
challenged communication dated 20.06.2014 issued by respondent
No.3-NPPA to the Department of Pharmaceutical, which purports
to interpret DPCO 2013, contrary
issued by the National
Pharmaceutical Pricing Authority (hereinafter referred to as,
"NPPA"), New Delhi, it being illegal and ex facie ultra vires ... impugned communication dated 6th/10th April,
2018 issued by NPPA addressed to the Petitioner and also to
the order dated 07/03/2018 and further
National Pharmaceutical Pricing
Authority (hereinafter referred to as the "NPPA"). The petitioner has
challenged communications dated 22nd June, 2012, 26th September ... December, 2012, addressed by the NPPA and a demand
notice dated 29th January, 2013 calling upon the petitioner to deposit
authority under its control i.e.
National Pharmaceutical Pricing Authority (NPPA). On this basis, it was
claimed that petitioner No.1 was liable to deposit ... interest upto 10.03.2015.
24. Thereafter, on 15.02.2016, the respondent No.1, through NPPA,
issued demand notice to the petitioner No.1, claiming that
that as per working schedule of NPPA, Wysolone DT 10 mg tablets
have been taken into consideration at the time of price fixation; and
hence ... Pharmaceuticals, Government of India. It was
mentioned in the memorandum that the NPPA i.e. the Respondent
No.3 was requested to comply with
after the said Drug Policy 1994, establish the National Pharmaceutical Pricing Authority (NPPA) as contemplated by the said Policy. The NPPA was finally notified ... Petitioners that significantly, however, the Respondents even after finally constituting the NPPA on 29th August, 1997 had sought to pre-empt its functioning by deleting
ordinate with SLA in the matter
Copy for information to:
1. Chairman, NPPA, 3rd/5th Floor, YMCA Cultural Center
Building 1, Jai Singh Road ... Delhi, 110001
(chairman.nppa@nic.in)
2. OSD, MoHFW, 243-A, Nirman Bhawan, New Delhi-
110011 (osd-mohfw
into consideration.
The price as determined by the National Pharmaceutical Pricing
Authority (NPPA) would bind the petitioner. All necessary
records be maintained by the petitioner
